Biotricity, Inc.
BTCY
$0.48
-$0.02-4.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.89M | 3.87M | 3.70M | 3.62M | 3.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.89M | 3.87M | 3.70M | 3.62M | 3.27M |
| Cost of Revenue | 704.30K | 757.20K | 724.40K | 855.10K | 807.70K |
| Gross Profit | 3.18M | 3.12M | 2.98M | 2.76M | 2.46M |
| SG&A Expenses | 2.30M | 2.14M | 3.26M | 2.38M | 2.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.61M | 3.59M | 4.56M | 3.79M | 3.57M |
| Operating Income | 273.80K | 281.90K | -855.50K | -169.00K | -307.70K |
| Income Before Tax | -690.90K | -672.00K | -1.94M | -1.23M | -1.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -690.90K | -672.00K | -1.94M | -1.23M | -1.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -690.90K | -672.00K | -1.94M | -1.23M | -1.56M |
| EBIT | 273.80K | 281.90K | -855.50K | -169.00K | -307.70K |
| EBITDA | 275.30K | 283.40K | -854.00K | -167.50K | -306.20K |
| EPS Basic | -0.03 | -0.03 | -0.08 | -0.05 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.05 | -0.03 | -0.04 |
| EPS Diluted | -0.03 | -0.03 | -0.08 | -0.05 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.05 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 26.77M | 26.28M | 26.35M | 24.23M | 22.49M |
| Average Diluted Shares Outstanding | 26.77M | 26.28M | 26.35M | 24.23M | 22.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.89% | -0.88% | -0.32% | -0.48% | -0.39% |